SCHEMBL5582025

SCHEMBL5582025

COc1ccc(Cn2c(-c3ccc(OC)cc3)nc3ccccc32)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 1.00
KDM4E B2RXH2 9/20 1.00
SMN1; SMN2 Q16637 6/20 1.00
HTT P42858 5/20 1.00
LMNA P02545 3/20 1.00
L3MBTL1 Q9Y468 2/20 1.00
CNR2 P34972 1/20 1.00
TP53 P04637 6/20 0.92
MAPT P10636 5/20 0.92
HPGD P15428 3/20 0.92
NPSR1 Q6W5P4 2/20 0.92
GAA P10253 3/20 0.84
NPC1 O15118 1/20 0.73
RAB9A P51151 1/20 0.73
TSHR P16473 2/20 0.72
HSD17B10 Q99714 2/20 0.72
PDE6D O43924 2/20 0.67
MEN1 O00255 1/20 0.67
KMT2A Q03164 1/20 0.67
HIF1A Q16665 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10443668 0.96 ALDH1A1 (0.92) ALDH1A1KDM4ESMN1; SMN2HTTLMNA
SCHEMBL8027362 0.89 KDM4E (0.79) ALDH1A1KDM4ESMN1; SMN2HTTLMNA
SCHEMBL10443667 0.86 ALDH1A1 (0.82) ALDH1A1KDM4ESMN1; SMN2HTTLMNA
SCHEMBL8022079 0.86 KDM4E (0.76) ALDH1A1KDM4ESMN1; SMN2HTTLMNA
SCHEMBL14006013 0.86 HTT (0.75) ALDH1A1KDM4ESMN1; SMN2HTTLMNA
SCHEMBL10080422 0.86 KDM4E (0.80) ALDH1A1KDM4ESMN1; SMN2HTTLMNA
SCHEMBL8393562 0.86 SMN1; SMN2 (0.73) ALDH1A1KDM4ESMN1; SMN2HTTLMNA
SCHEMBL5581775 0.85 TP53 (0.91) ALDH1A1KDM4ESMN1; SMN2HTTLMNA
SCHEMBL9042664 0.84 ALDH1A1 (0.71) ALDH1A1KDM4ESMN1; SMN2HTTLMNA
SCHEMBL10061946 0.84 KDM4E (1.00) ALDH1A1KDM4ESMN1; SMN2HTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012108689-A2 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR 부산대학교 산학협력단 (KR) 2012-08-16 WO claimed
US-20230295116-A1 PROTEASOME ENHANCERS AND USES THEREOF BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY 2023-09-21 US disclosed
US-20230295116-A1 PROTEASOME ENHANCERS AND USES THEREOF BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY 2023-09-21 US disclosed
CN-108997221-B Method for synthesizing 1, 2-disubstituted benzimidazole compound by using 3-hydroxy-2-naphthoic acid and dichlorotitanocene 陕西师范大学 2021-10-01 CN disclosed
CN-110845423-A Preparation method of 1, 2-substituted benzimidazole compound 井冈山大学 2020-02-28 CN disclosed
CN-108997221-A The method that 3- hydroxy-2-naphthoic acid cooperates with cyclopentadienyl titanium dichloride synthesis 1,2- disubstituted benzenes and glyoxaline compound 陕西师范大学 2018-12-14 CN disclosed
US-20150366776-A1 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREOF PUSAN NAT UNIV IND COOP FOUND (KR) 2015-12-24 US disclosed
US-20150366776-A1 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREOF PUSAN NAT UNIV IND COOP FOUND (KR) 2015-12-24 US disclosed
US-20150366776-A1 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREOF PUSAN NAT UNIV IND COOP FOUND (KR) 2015-12-24 US disclosed
US-9155690-B2 Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use thereof PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) 2015-10-13 US disclosed
US-8889881-B2 Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use therefor Pusan National University Industry —University Cooperation Foundation (KR) 2014-11-18 US disclosed
US-8889881-B2 Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use therefor Pusan National University Industry —University Cooperation Foundation (KR) 2014-11-18 US disclosed
US-20140037564-A1 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR Pusan National University Indusrtyuniversity (KR) 2014-02-06 US disclosed
US-20140037564-A1 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR Pusan National University Indusrtyuniversity (KR) 2014-02-06 US disclosed
US-20140037564-A1 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR Pusan National University Indusrtyuniversity (KR) 2014-02-06 US disclosed
WO-2012108689-A2 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR 부산대학교 산학협력단 (KR) 2012-08-16 WO disclosed
US-7193088-B2 Iridium complexes as light emitting materials and organic light emitting diode device CHI MEI OPTOELECTRONICS (TW) 2007-03-20 US disclosed
US-7193088-B2 Iridium complexes as light emitting materials and organic light emitting diode device CHI MEI OPTOELECTRONICS (TW) 2007-03-20 US disclosed
US-7193088-B2 Iridium complexes as light emitting materials and organic light emitting diode device CHI MEI OPTOELECTRONICS (TW) 2007-03-20 US disclosed
US-20050116626-A1 Iridium complexes as light emitting materials and organic light emitting diode device Innolux Corporation (TW) 2005-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150366776-A1 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREOF PPARG, PPARA, TYR ALDH1A1 213/4885KDM4E 3430/4885SMN1; SMN2 3671/4885
US-20140037564-A1 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR PPARG, PPARA, PPARD ALDH1A1 186/4885KDM4E 3588/4885SMN1; SMN2 4087/4885
US-20050116626-A1 Iridium complexes as light emitting materials and organic light emitting diode device ORC3, CRY1, ITGA1 ALDH1A1 282/4885KDM4E 4039/4885SMN1; SMN2 4300/4885
US-20230295116-A1 PROTEASOME ENHANCERS AND USES THEREOF PSME3, PSME4, ADRM1 ALDH1A1 2806/4885KDM4E 839/4885SMN1; SMN2 126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.